FibroGen Inc FGEN

NAS: FGEN | ISIN: US31572Q8087   30/04/2025
0,338 USD (+3,21%)
(+3,21%)   30/04/2025

6 augustus 2022 · FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Provides Update of its Investigation of the Officers and Directors of FibroGen, Inc. - FGEN · Persbericht

14 mei 2022 · FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of FibroGen, Inc. - FGEN · Persbericht

20 augustus 2021 · Astellas Receives European Commission Approval for First-in-Class EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease · Persbericht

25 juni 2021 · Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease · Persbericht

11 juni 2021 · FIBROGEN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against FibroGen, Inc. - FGEN · Persbericht

7 juni 2021 · Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against FibroGen, Inc. · Persbericht

2 juni 2021 · Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. · Persbericht

28 mei 2021 · Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN) · Persbericht

26 mei 2021 · Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. (FGEN) · Persbericht

21 mei 2021 · DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in FibroGen, Inc. Securities Fraud Class Action Lawsuit · Persbericht

17 mei 2021 · FGEN INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fibrogen Inc. · Persbericht

16 mei 2021 · FGEN ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. - Expanded Class Period · Persbericht

11 mei 2021 · HAGENS BERMAN Alerts FibroGen (FGEN) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors Should Secure Counsel · Persbericht

10 mei 2021 · Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for FibroGen, Inc. Investors - Expanded Class Period · Persbericht

5 mei 2021 · FGEN Reminder: Kessler Topaz Meltzer & Check, LLP - Deadline Reminder for FibroGen, Inc. Investors · Persbericht

5 mei 2021 · Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN) · Persbericht

1 mei 2021 · Pomerantz Law Firm Announces the Filing of a Class Action Against FibroGen, Inc. and Certain Officers - FGEN · Persbericht

30 april 2021 · Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds FibroGen, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

24 april 2021 · Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. (FGEN) · Persbericht

19 april 2021 · Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for FibroGen, Inc. Investors in Securities Fraud Class Action Lawsuit · Persbericht

Mijn selecties